Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 2979-06-8 | MDL No. : | MFCD00210460 |
Formula : | C11H12O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ZOQCEVXVQCPESC-VMPITWQZSA-N |
M.W : | 192.21 | Pubchem ID : | 676946 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.18 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 54.26 |
TPSA : | 46.53 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.61 cm/s |
Log Po/w (iLOGP) : | 2.32 |
Log Po/w (XLOGP3) : | 2.63 |
Log Po/w (WLOGP) : | 1.86 |
Log Po/w (MLOGP) : | 1.88 |
Log Po/w (SILICOS-IT) : | 2.1 |
Consensus Log Po/w : | 2.16 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.74 |
Solubility : | 0.348 mg/ml ; 0.00181 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.26 |
Solubility : | 0.106 mg/ml ; 0.000553 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.4 |
Solubility : | 0.772 mg/ml ; 0.00402 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.04 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362 | UN#: | N/A |
Hazard Statements: | H315-H319 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 3943-97-3 ]
Methyl 3-(4-hydroxyphenyl)acrylate
Similarity: 0.95
[ 74257-25-3 ]
(Z)-Ethyl 3-(3,4-dihydroxyphenyl)acrylate
Similarity: 0.93
[ 1929-30-2 ]
Ethyl 3-(4-methoxyphenyl)acrylate
Similarity: 0.93
[ 66417-46-7 ]
Methyl trans-3-Hydroxycinnamate
Similarity: 0.93
[ 17041-46-2 ]
Ethyl 3-(2-hydroxyphenyl)acrylate
Similarity: 0.91
[ 3943-97-3 ]
Methyl 3-(4-hydroxyphenyl)acrylate
Similarity: 0.95
[ 74257-25-3 ]
(Z)-Ethyl 3-(3,4-dihydroxyphenyl)acrylate
Similarity: 0.93
[ 1929-30-2 ]
Ethyl 3-(4-methoxyphenyl)acrylate
Similarity: 0.93
[ 66417-46-7 ]
Methyl trans-3-Hydroxycinnamate
Similarity: 0.93
[ 17041-46-2 ]
Ethyl 3-(2-hydroxyphenyl)acrylate
Similarity: 0.91
[ 3943-97-3 ]
Methyl 3-(4-hydroxyphenyl)acrylate
Similarity: 0.95
[ 74257-25-3 ]
(Z)-Ethyl 3-(3,4-dihydroxyphenyl)acrylate
Similarity: 0.93
[ 1929-30-2 ]
Ethyl 3-(4-methoxyphenyl)acrylate
Similarity: 0.93
[ 66417-46-7 ]
Methyl trans-3-Hydroxycinnamate
Similarity: 0.93
[ 17041-46-2 ]
Ethyl 3-(2-hydroxyphenyl)acrylate
Similarity: 0.91